July 8, 2014 / 11:59 AM / 5 years ago

Jean Coutu sales rise on generic drug demand, store addition

(Reuters) - Canadian pharmacy chain Jean Coutu Group Inc PJCa.TO reported higher quarterly sales, helped by demand for its high-margin generic drugs and the expansion of its network of franchised stores.

Jean Coutu has been adding smaller-sized stores in smaller markets where it has seen a rise in prescription drugs sales.

Gross sales of Jean Coutu’s Pro Doc drugs rose to C$48.3 million in the quarter from C$45.7 million a year earlier. Jean Coutu sells its own generic drugs mainly in Quebec, its biggest market.

Jean Coutu has faced a ban on sales of private-label generic drugs to control prescription costs in regions like Ontario. The Longueuil, Quebec-based company’s revenue rose 1 percent to C$688.6 million.

The company’s same-store sales rose 0.1 percent in the quarter, compared with a 0.6 percent rise a year earlier.

Net profit halved to C$54.1 million ($50.64 million), or 29 Canadian cents per share, in the first quarter ended May 31, from C$108.6 million, or 51 Canadian cents per share, a year earlier.

The company had reported a gain of C$54.4 million related to the investment in Rite Aid a year earlier.

Jean Coutu shares closed down 0.67 percent at C$22.20 on the Toronto Stock Exchange on Monday. The company’s stock has risen more than 28.5 percent in the 12 months to Monday’s close, outperforming the TSX-Toronto Stock Exchange 300 Composite Index .GSPTSE 25 percent increase.

($1 = 1.0684 Canadian Dollars)

Reporting By Shubhankar Chakravorty in Bangalore

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below